BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17441398)

  • 21. Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice.
    Trigg ME; Higa GM
    J Oncol Pharm Pract; 2010 Dec; 16(4):233-44. PubMed ID: 20085961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Putting evidence into practice: evidence-based interventions for the prevention and management of constipation in patients with cancer.
    Woolery M; Bisanz A; Lyons HF; Gaido L; Yenulevich M; Fulton S; McMillan SC
    Clin J Oncol Nurs; 2008 Apr; 12(2):317-37. PubMed ID: 18390467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating aprepitant and palonosetron into clinical practice: a role for the new antiemetics.
    Viale PH
    Clin J Oncol Nurs; 2005 Feb; 9(1):77-84. PubMed ID: 15751501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiemetic therapy in patients receiving cancer chemotherapy.
    Marek C
    Oncol Nurs Forum; 2003; 30(2):259-71. PubMed ID: 12692660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy-induced nausea and vomiting.
    Lohr L
    Cancer J; 2008; 14(2):85-93. PubMed ID: 18391612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolving paradigms in chemotherapy-induced nausea and vomiting and symptom management for the breast cancer patient.
    Biedrzycki BA
    ONS Connect; 2007; 22(8 Suppl):9-10. PubMed ID: 17824543
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.
    Jordan K; Kasper C; Schmoll HJ
    Eur J Cancer; 2005 Jan; 41(2):199-205. PubMed ID: 15661543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Putting evidence into practice: evidence-based interventions for sleep-wake disturbances.
    Page MS; Berger AM; Johnson LB
    Clin J Oncol Nurs; 2006 Dec; 10(6):753-67. PubMed ID: 17193942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical roundtable monograph. Treatment of chemotherapy-induced nausea and vomiting: a post-MASCC 2010 discussion.
    Kris MG; Urba SG; Schwartzberg LS
    Clin Adv Hematol Oncol; 2011 Jan; 9(1):suppl 1-15. PubMed ID: 21370520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy-induced nausea and vomiting (CINV): prevention, detection, and treatment--how are we doing?
    ONS News; 2004; 19(9 Suppl):61-2. PubMed ID: 15478591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
    Navari RM
    J Support Oncol; 2003; 1(2):89-103. PubMed ID: 15352652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylaxis of acute chemotherapy-induced nausea and vomiting in children with cancer: what is the evidence?
    Antonarakis ES; Evans JL; Heard GF; Noonan LM; Pizer BL; Hain RD
    Pediatr Blood Cancer; 2004 Nov; 43(6):651-8. PubMed ID: 15390297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of nausea.
    Jenns K
    Cancer Nurs; 1994 Dec; 17(6):488-93. PubMed ID: 7820827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ensuring consistency among evidence-based practice interventions.
    Mitchell C
    Clin J Oncol Nurs; 2008 Apr; 12(2):365-7. PubMed ID: 18390471
    [No Abstract]   [Full Text] [Related]  

  • 36. Review of palonosetron: emerging data distinguishing it as a novel 5-HT(3) receptor antagonist for chemotherapy-induced nausea and vomiting.
    Saito M; Tsukuda M
    Expert Opin Pharmacother; 2010 Apr; 11(6):1003-14. PubMed ID: 20307224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nurse's role in managing chemotherapy-induced nausea and vomiting: an international survey.
    Krishnasamy M; Kwok-Wei So W; Yates P; de Calvo LE; Annab R; Wisniewski T; Aranda S
    Cancer Nurs; 2014; 37(4):E27-35. PubMed ID: 24145248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and cost effectiveness of new antiemetic guidelines.
    Engstrom C; Hernandez I; Haywood J; Lilenbaum R
    Oncol Nurs Forum; 1999 Oct; 26(9):1453-8. PubMed ID: 11064877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice.
    Antonarakis ES; Hain RD
    Arch Dis Child; 2004 Sep; 89(9):877-80. PubMed ID: 15321871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy-induced nausea and vomiting: clinician and patient perspectives.
    Schwartzberg LS
    J Support Oncol; 2007 Feb; 5(2 Suppl 1):5-12. PubMed ID: 17366928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.